Journal of Okayama Medical Association
Published by Okayama Medical Association<Availability>
Full-text articles are available 3 years after publication.
Permalink : http://escholarship.lib.okayama-u.ac.jp/53537
A prospective cohort study to define the clinical and pathological features of lung cancers harboring HER2 gene aberrations (the HER2-CS Study) and a phase II study of trastuzumab emtansine (recombinant) in patients with HER2-positive non-small cell lung cancer who recurred, progressed after standard chemotherapy, or were primarily refractory to standard chemotherapy
Sato, Akiko
Ninomiya, Takashi
Minnami, Daisuke
Tabata, Masahiro
Kaken ID
researchmap
Kubo, Toshio
Kaken ID
researchmap
Kato, Yuka
Kaken ID
Hirata, Taizo
Published Date
2015-08-03
Keywords
臨床研究中核病院
国立研究開発法人日本医療研究開発機構
文部科学省橋渡し研究加速ネットワークプログラム
HER2-CS study
trastuzumab emtansine
Note
特集(Feature Articles)
DOI
ISSN
0030-1558
NCID
AN00032489
NAID